Thomas Smeenk, BA, Co-Founder, President & CEO

  • Founder, President and VP Business Development, TheraVitae Inc., which went public as Hemostemix Inc. QT.
  • A finance and business development executive with a proven track record of bringing new discoveries to market.
  • A public company executive since 1996, serving most recently as President & CEO of Broadway Gold Mining Ltd, where he completed a $30  million agreement with Rio Tinto. Prior, VP Business Development, Memex Inc. (TSXV:MEM); President & CEO of e-Manufacturing Networks Inc. (TSXV:OEE); President and CEO of Tyranex Gold Inc. and President and CEO of IBI Corporation